Texas Biochemicals Inc.

College Station, TX

UEI
ND71US7MF6Z5
CAGE
4FQS9
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
7610 Eastmark Dr #106, College Station, TX 77840, USA
Founded
2006
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Information Technology
  2. Technology Hardware & Equipment
  3. Electronic Equipment, Instruments & Components
  4. Nanotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $500,000
FY2025 $2,066,376
FY2024 $301,499

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of the Navy $500,000

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Texas Biochemicals Inc. is a minority-owned, self-certified small disadvantaged business headquartered in College Station, Texas, that specializes in research and development services for federal defense and aerospace agencies. The company, registered with SAM.gov since June 2006, operates as a for-profit corporate entity with Subcontinent Asian (Asian-Indian) American ownership. Texas Biochemicals Inc. provides innovative coating and materials technology solutions to support mission-critical applications within the federal defense sector, leveraging small business innovation programs to develop advanced protective systems.

Texas Biochemicals Inc. has secured three prime federal contract awards totaling approximately $2.37 million across two federal agencies. The company's primary focus has been the development of cost-effective, scalable, and electrically conductive spray coatings for lightning strike protection, which represents a specialized research and development capability. The Missile Defense Agency has awarded two sequential Small Business Innovation Research (SBIR) contracts: a Phase I award of $155,000 (Firm Fixed Price contract, awarded August 1, 2024, completing April 4, 2025) and a Phase II contract valued at $1.97 million (Cost-Plus-Fixed-Fee contract, awarded September 22, 2025, completing September 21, 2027). Additionally, the Naval Air Warfare Center awarded Texas Biochemicals Inc. a Small Business Technology Transfer (STTR) Phase I contract valued at $246,498 (Firm Fixed Price contract, awarded July 11, 2024, completing November 10, 2025) under topic N24A-T006. All three contracts have been designated as Total Small Business set-asides, reflecting the company's qualified status as a small business. The work has been and will be performed at the company's College Station, Texas facility, positioning Texas Biochemicals Inc. as a specialized research and development provider supporting advanced materials innovation for defense applications.

Quick answers

Is Texas Biochemicals Inc. registered in SAM.gov?

Yes. Texas Biochemicals Inc.'s SAM.gov registration is active through May 11, 2027.

How much has Texas Biochemicals Inc. received in federal contracts?

Federal contracts obligated $2,066,376 to Texas Biochemicals Inc. in fiscal year 2025 and $2,867,875 in fiscal years 2023 through 2027.

What is Texas Biochemicals Inc.'s most recent federal award?

Texas Biochemicals Inc.'s most recent federal contract award is Research and development (N6833526C0028), from Naval Air Warfare Center (NAVAIR), on November 3, 2025.

On GovTribe

See Texas Biochemicals Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors